Asset Management One’s Sarepta Therapeutics SRPT Stock Holding History

Asset Management One’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,918	Closed	-$2.53M	–	1073
2021 Q1	$2.53M	Sell	33,918 -1,356	-4%	-$125K	0.01%	778
2020 Q4	$6.06M	Sell	35,274 -722	-2%	-$107K	0.03%	596
2020 Q3	$5.06M	Sell	35,996 -893	-2%	-$136K	0.02%	577
2020 Q2	$5.92M	Sell	36,889 -562	-2%	-$76.5K	0.03%	523
2020 Q1	$3.66M	Sell	37,451 -263	-0.7%	-$30.1K	0.02%	582
2019 Q4	$4.87M	Hold	37,714	–	–	0.02%	630
2019 Q3	$2.84M	Buy	+37,714	New	+$4.45M	0.01%	737
2016 Q4	–	Sell	-1,490	Closed	-$90K	–	1184
2016 Q3	$90K	Buy	+1,490	New	+$45K	﹤0.01%	1277
2013 Q4	–	Sell	-10,448	Closed	-$490K	–	1136
2013 Q3	$490K	Buy	+10,448	New	+$402K	0.01%	920

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Asset Management One's SRPT Position: Q2 2021 in Review

Asset Management One sold out of Sarepta Therapeutics (SRPT) in Q2 2021, closing a stake of 33,918 shares — an estimated $2.53M sold.

Asset Management One first reported a position in SRPT in Q3 2013 and held it in 9 quarters. The position peaked at $6.06M in Q4 2020. 330 funds tracked by Wall St. Rank hold SRPT as of Q2 2021.

Asset Management One reported no remaining Sarepta Therapeutics position as of Q2 2021 after selling out during the quarter.
Asset Management One sold 33,918 Sarepta Therapeutics shares in Q2 2021, an estimated $2.53M.
Asset Management One first reported a position in Sarepta Therapeutics in Q3 2013 and held it in 9 quarters.
Asset Management One's Sarepta Therapeutics position peaked at $6.06M in Q4 2020.
330 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2021.

Based on Asset Management One's 13F filing for Q2 2021, filed 3 Aug 2021.